StockMarketWire.com - Reed Elsevier has appointed David Brennan as a member of the Supervisory Board of Reed Elsevier NV and as a non-executive director of Reed Elsevier PLC subject to shareholder approval at the respective Annual General Meetings to be held on 24 and 25 April 2012. He will also be appointed a non-executive director of Reed Elsevier Group plc.

Brennan is currently the Chief Executive Officer of AstraZeneca PLC, a global biopharmaceutical company,



Story provided by StockMarketWire.com